Home/Filings/4/0001209191-17-038326
4//SEC Filing

MERRIMACK PHARMACEUTICALS INC 4

Accession 0001209191-17-038326

CIK 0001274792operating

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:46 PM ET

Size

5.5 KB

Accession

0001209191-17-038326

Insider Transaction Report

Form 4
Period: 2017-06-06
Munsie Jeffrey A
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2017-06-06+550,000550,000 total
    Exercise: $1.45Exp: 2027-06-05Common Stock (550,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 1/12th of the total number of shares granted on 9/6/17 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 6/6/20.

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001274792

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:46 PM ET
Size
5.5 KB